ArticleNature genetics2017

Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer.

Luca Magnani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.